Answers are grounded in this paper and cite their sources.
D1.7 establishes the SPARC Ethics Framework and Security Guidelines under WP1, Task 1.6. It sets common principles and practical guidance for personalised cancer medicine, using the ongoing pilots to inform, test and progressively validate their application. Pilot experience, stakeholder input and emerging evidence will guide refinements during implementation and the update in D1.8 at M34. Each activity remains subject to applicable law, competent authorities, Research Ethics Committees (RECs), institutional requirements and professional duties.
No takes yet. Share an insight, caveat, or question.
Muntañola-Valero et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: